Related references
Note: Only part of the references are listed.Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC
Fang-Ju Cheng et al.
ONCOGENE (2021)
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs
Chia-Hung Chen et al.
ONCOGENE (2021)
Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
Peter T. Harrison et al.
SEMINARS IN CANCER BIOLOGY (2020)
Lactate: A Metabolic Driver in the Tumour Landscape
Luigi Ippolito et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments
Yasna Contreras-Baeza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
Karen G. de la Cruz-Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy
Pascale Fisel et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
Maria Apicella et al.
CELL METABOLISM (2018)
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
Pei-Chih Lee et al.
CANCER CELL (2018)
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD plus Depletion in Cancer Cells
Don Benjamin et al.
CELL REPORTS (2018)
The Influence of Metabolism on Drug Response in Cancer
Esther A. Zaal et al.
FRONTIERS IN ONCOLOGY (2018)
Protein kinase C in cancer: The top five unanswered questions
Mariana Cooke et al.
MOLECULAR CARCINOGENESIS (2017)
Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer
Mingtong Ye et al.
JOURNAL OF CANCER (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
Na+/H+ antiporter (NHE1) and lactate/H+ symporters (MCTs) in pH homeostasis and cancer metabolism
Laurent Counillon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
Sophie Taylor et al.
DRUG RESISTANCE UPDATES (2015)
Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC-/ERK1/2 pathway: An in vitro investigation
Xu-Dong Cheng et al.
MOLECULAR MEDICINE REPORTS (2015)
The protein kinase C (PKC) inhibitors combined with chemotherapy in the treatment of advanced non-small cell lung cancer: meta-analysis of randomized controlled trials
L. L. Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Role of Monocarboxylate Transporters in Drug Delivery to the Brain
Nisha Vijay et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Protein Kinase C, Focal Adhesions and the Regulation of Cell Migration
Betina S. Fogh et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma
C. D. Hudson et al.
CELL DEATH & DISEASE (2014)
Lactic Acidosis in Patients With Cancer
Jeanne Held-Warmkessel et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2014)
Protein kinase C pharmacology: refining the toolbox
Alyssa X. Wu-Zhang et al.
BIOCHEMICAL JOURNAL (2013)
Acidic extracellular microenvironment and cancer
Yasumasa Kato et al.
CANCER CELL INTERNATIONAL (2013)
Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Ethan B. Butler et al.
CANCER RESEARCH (2013)
The SLC16 gene family - Structure, role and regulation in health and disease
Andrew P. Halestrap
MOLECULAR ASPECTS OF MEDICINE (2013)
Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Protons and Ca2+: Ionic Allies in Tumor Progression?
Maike Glitsch
PHYSIOLOGY (2011)
Protein Kinase C: An Attractive Target for Cancer Therapy
Barbara Marengo et al.
Cancers (2011)
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
J. Hao et al.
BRITISH JOURNAL OF CANCER (2010)
Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression
Hongmin Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
William Pao et al.
NATURE REVIEWS CANCER (2010)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Small cell lung cancer
Taimur Sher et al.
MAYO CLINIC PROCEEDINGS (2008)
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing
Lecia V. Sequist et al.
ONCOLOGIST (2007)
Protein kinase C erectors bind to multidrug ABC transporters and inhibit their activity
G Conseil et al.
BIOCHEMISTRY (2001)
Protein kinase C isozymes and the regulation of diverse cell responses
EC Dempsey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
Share Paper
